These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9603795

  • 1. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
    Tybjaerg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG.
    N Engl J Med; 1998 May 28; 338(22):1577-84. PubMed ID: 9603795
    [Abstract] [Full Text] [Related]

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov 28; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 3. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
    Tybjaerg-Hansen A, Jensen HK, Benn M, Steffensen R, Jensen G, Nordestgaard BG.
    Arterioscler Thromb Vasc Biol; 2005 Jan 28; 25(1):211-5. PubMed ID: 15528480
    [Abstract] [Full Text] [Related]

  • 4. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC, Pricker KL, Hayden MR, van der Ende BE, Kastelein JJ.
    Arch Intern Med; 1993 Oct 25; 153(20):2349-56. PubMed ID: 8215738
    [Abstract] [Full Text] [Related]

  • 5. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar 25; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

  • 6. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
    Schaefer JR, Herzum M, Maisch B.
    N Engl J Med; 1998 Nov 26; 339(22):1641-2. PubMed ID: 9867530
    [No Abstract] [Full Text] [Related]

  • 7. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D, Schuster H, Zöllner N.
    Eur J Med Res; 1996 May 24; 1(8):383-6. PubMed ID: 9360938
    [Abstract] [Full Text] [Related]

  • 8. Familial defective apolipoprotein B-100.
    Hansen PS.
    Dan Med Bull; 1998 Sep 24; 45(4):370-82. PubMed ID: 9777289
    [Abstract] [Full Text] [Related]

  • 9. Familial hypercholesterolemia and coronary heart disease: a HuGE association review.
    Austin MA, Hutter CM, Zimmern RL, Humphries SE.
    Am J Epidemiol; 2004 Sep 01; 160(5):421-9. PubMed ID: 15321838
    [Abstract] [Full Text] [Related]

  • 10. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
    Wittrup HH, Tybjaerg-Hansen A, Abildgaard S, Steffensen R, Schnohr P, Nordestgaard BG.
    J Clin Invest; 1997 Apr 01; 99(7):1606-13. PubMed ID: 9120004
    [Abstract] [Full Text] [Related]

  • 11. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW, Kastelein JJ, Defesche JC.
    Hum Mutat; 2005 Dec 01; 26(6):550-6. PubMed ID: 16250003
    [Abstract] [Full Text] [Related]

  • 12. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L, Levy E, Feoli-Fonseca JC, Godbout C, Lambert M.
    Pediatrics; 1995 Aug 01; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [Abstract] [Full Text] [Related]

  • 13. Hyperinsulinemia as an independent risk factor for ischemic heart disease.
    Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ.
    N Engl J Med; 1996 Apr 11; 334(15):952-7. PubMed ID: 8596596
    [Abstract] [Full Text] [Related]

  • 14. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW, Defesche JC, Kastelein JJ, Sijbrands EJ.
    Semin Vasc Med; 2004 Aug 11; 4(3):259-64. PubMed ID: 15630635
    [Abstract] [Full Text] [Related]

  • 15. [Prevention of coronary heart disease in familial hypercholesterolemia].
    Miserez AR, Keller U.
    Ther Umsch; 1994 Oct 11; 51(10):671-6. PubMed ID: 7839323
    [Abstract] [Full Text] [Related]

  • 16. [Clinical manifestations of familial hypercholesterolemia in Mediterranean population].
    Alonso-Villaverde C, Sardà P, Vallbé JC, Heras M, Pérez-Jiménez F, Pedro-Botet JC, Ros-Rahola E, Masana L.
    Med Clin (Barc); 1999 Oct 30; 113(14):521-5. PubMed ID: 10605666
    [Abstract] [Full Text] [Related]

  • 17. Rare and common mutations in hyperlipidemia and atherosclerosis. With special reference to familial defective apolipoprotein B-100.
    Tybjaerg-Hansen A.
    Scand J Clin Lab Invest Suppl; 1995 Oct 30; 220():57-76. PubMed ID: 7652481
    [Abstract] [Full Text] [Related]

  • 18. Trends in serum cholesterol levels from 1980 to 1987. The Minnesota Heart Survey.
    Burke GL, Sprafka JM, Folsom AR, Hahn LP, Luepker RV, Blackburn H.
    N Engl J Med; 1991 Apr 04; 324(14):941-6. PubMed ID: 2002818
    [Abstract] [Full Text] [Related]

  • 19. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
    Guardamagna O, Restagno G, Rolfo E, Pederiva C, Martini S, Abello F, Baracco V, Pisciotta L, Pino E, Calandra S, Bertolini S.
    J Pediatr; 2009 Aug 04; 155(2):199-204.e2. PubMed ID: 19446849
    [Abstract] [Full Text] [Related]

  • 20. [Frequent mutation doubles the risk of ischemic heart disease in women].
    Wittrup HH, Tybjaerg-Hansen A, Abildgaard S, Steffensen R, Schnohr P, Nordestgaard BG.
    Ugeskr Laeger; 1998 Jun 29; 160(27):4067-72. PubMed ID: 9659837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.